Advantage Alpha Capital Partners LP Dynavax Technologies Corp Transaction History
Advantage Alpha Capital Partners LP
- $419 Million
- Q3 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 46,151 shares of DVAX stock, worth $602,270. This represents 0.12% of its overall portfolio holdings.
Number of Shares
46,151
Previous 80,250
42.49%
Holding current value
$602,270
Previous $901,000
42.95%
% of portfolio
0.12%
Previous 0.2%
Shares
4 transactions
Others Institutions Holding DVAX
# of Institutions
273Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$286 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$163 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$120 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$109 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$100 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.65B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...